David P. JoyceSell
Fund · Transaction Feb 17, 2017 · Filed Jul 26, 2017 · $1,001 to $15,000
XNAS · IBB
+3.00% · +$6.02 · Vol 2.5M
Market closed · last close 4:00 PM ET · price as of 18:29:17 ET
IBB
iShares Biotechnology ETF
$206.50
Follow $IBB
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $IBB by emailVeridion Score
BETAFund score · valuation-exemptMEDIUM CONF · 4 of 5 factors measuredFri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET · IBB
MethodologyFund Flow absence reason unknown
IBB
iShares Biotechnology ETF
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Fund-class market intelligence score across five applicable factors. Company valuation and earnings inputs are excluded.
49/ 100
Veridion Score
Middle range · MEDIUM confidence · 4 of 5 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Momentum · attention · fund flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 4 of 5 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is IBB moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About iShares Biotechnology ETF
Listed since
2001
Country
US
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$201.05
Day high
$206.79
Day low
$200.53
Previous close
$200.48
52W high
$216.96
-4.82% from high
52W low
$150.94
84% of range
Beta
0.57
Shares out
52.8M
Volume
2.5M
1.48× rel vol
Avg volume
1.7M
VWAP
$205.26
Price history computed in-house
1W
+0.59%
1M
+1.76%
3M
+8.94%
1Y
+37.71%
YTD
+22.36%
SMA 50 $205.29 · above
SMA 200 $181.94 · above
52W position 84%
IBB overview
Related filings and maps
Financials
Company financial statements are not applicable for IBB.
Public disclosures
Congress activity in IBB
4 filers · 2 buys · 3 sells (0 labeled S (partial)) · May 25, 2016 to Feb 17, 2017 · House 5 / Senate 0
All available history · Latest 5 of 5 lines · Read 2026-10-11T03:58:57.499Z
Official filing ↗
Disclosed security · Transaction Dec 30, 2016 · Filed Jan 10, 2017 · $1,001 to $15,000
Richard L. HannaSell
Fund · Transaction Dec 28, 2016 · Filed Jan 18, 2017 · $1,001 to $15,000
Fund · Transaction May 31, 2016 · Filed Jul 12, 2016 · $15,001 to $50,000
Disclosed security · Transaction May 25, 2016 · Filed Jun 16, 2016 · $1,001 to $15,000
Federal contracts
IBB contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IBB in this window.
Lobbying spend
IBB lobbying filings, year to date.
Registered lobbying filings matched to iShares Biotechnology ETF.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IBB in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for IBB.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.